Skip to main content
Clinical Trials/NCT07400237
NCT07400237
Recruiting
Not Applicable

Laparoscopic Ultrasound Versus Fluorescence Cholangiography in Technically Challenging Laparoscopic Cholecystectomy. Multicenter Comparative Study

Consorci Sanitari Integral1 site in 1 country62 target enrollmentStarted: April 1, 2025Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
62
Locations
1
Primary Endpoint
Clear intraoperative identification of the junction between the cystic duct, the common hepatic duct, and the common bile duct

Overview

Brief Summary

This is a multicenter, prospective, interventional clinical trial designed to evaluate and compare two intraoperative imaging modalities: laparoscopic ultrasound (LUS) and fluorescence cholangiography with indocyanine green (ICG), for the identification of biliary anatomy in technically challenging laparoscopic cholecystectomy. All enrolled subjects will undergo both LUS and ICG during the index procedure, following a standardized sequence, in order to allow intra-subject comparison. LUS will be performed first, followed by fluorescence cholangiography prior to Calot's triangle dissection.

The primary endpoint is the successful identification of the critical junction. Secondary endpoints include visualization of individual biliary structures, time to visualization, total operative time, intraoperative and postoperative complications.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 18 years.
  • Written informed consent provided.
  • Indication for laparoscopic cholecystectomy with anticipated technical difficulty due to one or more of the following:
  • Acute cholecystitis.
  • Previous cholangitis, pancreatitis, or endoscopic retrograde cholangiopancreatography.
  • Prior upper abdominal surgery.
  • Obesity (Body Mass Index ≥ 30 kg/m²).

Exclusion Criteria

  • Known allergy to ICG or iodine.
  • Pregnancy or breastfeeding.
  • High risk of choledocholithiasis (ESGE guidelines).
  • Thyroid disease.
  • Suspected gallbladder malignancy.
  • ASA class IV-V.
  • Chronic kidney disease stage \> IIIb.
  • Planned open cholecystectomy.

Arms & Interventions

Complex laparoscopic cholecystectomy

Other

Laparoscopic cholecystectomy with anticipated technical difficulty

Intervention: Laparoscopic ultrasound (LUS) and fluorescence cholangiography with indocyanine green (ICG) (Diagnostic Test)

Outcomes

Primary Outcomes

Clear intraoperative identification of the junction between the cystic duct, the common hepatic duct, and the common bile duct

Time Frame: Intraoperative

This intraoperative visualization will be assessed separately for laparoscopic ultrasound (LUS) and indocyanine green fluorescence cholangiography (ICG) and recorded as a binary outcome (yes/no) for each technique in each patient using a standardized intraoperative assessment form completed by the operating surgeon. Laparoscopic ultrasound will be performed first, followed by indocyanine green fluorescence cholangiography, according to a predefined and standardized intraoperative sequence. Intraoperative photographic documentation will be obtained for each imaging modality to objectively demonstrate the visualization of the critical biliary junction. Results will be reported as the proportion of patients with successful visualization for each modality and compared using an intra-subject analysis.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials